Cleerly ISCHEMIA vs LINQ II Insertable Cardiac Monitor

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
Cleerly ISCHEMIA
by Cleerly
VS
LINQ II Insertable Cardiac Monitor
by Medtronic

AI Verdict

Cleerly ISCHEMIA and the Medtronic LINQ II are both AI-powered tools for cardiac diagnosis but address distinct aspects of heart health. Cleerly ISCHEMIA focuses on non-invasive detection of coronary artery ischemia and plaque characterization using CCTA scans. In contrast, the LINQ II is an insertable cardiac monitor designed for long-term, continuous detection and diagnosis of arrhythmias. Therefore, while both leverage AI in cardiology, they serve different diagnostic purposes for different cardiac conditions.

Choose Cleerly ISCHEMIA if…

Choose Cleerly ISCHEMIA if you need a non-invasive, detailed assessment of coronary artery disease, including the likelihood of ischemia at a vessel level. This tool is ideal for physicians utilizing CCTA scans to characterize coronary plaque, assess stenosis severity, and inform personalized treatment plans for heart disease.

View Cleerly ISCHEMIA →

Choose LINQ II Insertable Cardiac Monitor if…

Choose the LINQ II Insertable Cardiac Monitor if long-term, continuous heart rhythm monitoring is required to diagnose infrequent or paroxysmal arrhythmias. This device is particularly well-suited for patients needing extended monitoring (up to 4.5 years), including pediatric patients, and benefits from AI-powered accuracy and remote management capabilities.

View LINQ II Insertable Cardiac Monitor →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Cleerly ISCHEMIA LINQ II Insertable Cardiac Monitor
Deployment Web-based solution Subcutaneous implant with remote monitoring via mobile app or home communicator.
BAA Available Yes AI-estimated Unknown
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

LINQ II Insertable Cardiac Monitor

Tool B offers a more comprehensive and integrated user experience across the care continuum, including a patient-facing mobile app and remote programming for clinicians, which simplifies long-term monitoring. Tool A's usability is primarily focused on the clinician's interaction with a web-based analysis platform and reports.

Clinical Value

Cleerly ISCHEMIA

Cleerly ISCHEMIA (Tool A) provides a transformative, non-invasive diagnostic pathway for coronary artery disease by offering functional assessment (FFR) and detailed plaque characterization from a single CCTA scan. While Tool B offers critical long-term arrhythmia detection, Tool A's comprehensive diagnostic information from a non-invasive test represents a significant advancement in guiding personalized treatment for CAD.

Pricing & Value

Tie

Both tools lack transparent public pricing, making it impossible to conduct a direct cost-benefit analysis or compare their overall value proposition. Neither offers a free trial, further limiting insight into potential value.

Enterprise Readiness

LINQ II Insertable Cardiac Monitor

Medtronic (Tool B) demonstrates superior enterprise readiness due to its long-standing history as a global medical device leader, extensive customer base with over a million patients worldwide, and established infrastructure capable of supporting diverse healthcare systems. Cleerly (Tool A), while compliant and integrated, is a newer company with less demonstrated scale.

Innovation

Cleerly ISCHEMIA

Cleerly ISCHEMIA's (Tool A) ability to non-invasively estimate fractional flow reserve (FFR) and provide detailed coronary plaque characterization from a standard CCTA scan is a highly innovative and potentially disruptive advancement. This offers a non-invasive alternative to traditionally invasive or separate functional tests for coronary artery disease.

Support & Docs

LINQ II Insertable Cardiac Monitor

Medtronic (Tool B) provides significantly more comprehensive and readily accessible support and documentation, including dedicated technical and patient service lines, detailed clinician and patient manuals, and online resources like videos. Cleerly (Tool A) lacks comparable publicly available structured support information.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Cleerly ISCHEMIA LINQ II Insertable Cardiac Monitor
Product Name Cleerly ISCHEMIA LINQ II Insertable Cardiac Monitor
Company Cleerly Medtronic
Core Functionality Analyzes CCTA scans to non-invasively determine the likelihood of coronary artery ischemia at a vessel level. Provides long-term, continuous heart rhythm monitoring for diagnosing arrhythmias.
Tagline AI-Powered Precision for Non-Invasive Ischemia Detection Advanced insertable cardiac monitoring with AI-powered accuracy and remote management.
Primary AI Application AI-enabled CCTA analysis, non-invasive fractional flow reserve (FFR) estimation, vessel-level ischemia likelihood determination. AccuRhythmu2122 AI algorithms for enhanced accuracy, innovative PVC detection algorithm.
Target Specialties Cardiology, Radiology Cardiology

Videos

Demos, reviews, and walkthroughs featuring Cleerly ISCHEMIA and LINQ II Insertable Cardiac Monitor.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Cleerly ISCHEMIA is an FDA-cleared AI tool designed to analyze CCTA scans to non-invasively determine the likelihood of coronary artery ischemia at a vessel level, aiding in personalized diagnosis and treatment planning for heart disease. In contrast, the Medtronic LINQ II is an AI-powered insertable cardiac monitor providing long-term, continuous heart rhythm monitoring for diagnosing arrhythmias.
Cleerly ISCHEMIA is a non-invasive tool that analyzes existing Coronary Computed Tomography Angiography (CCTA) scans to provide insights into coronary plaque, stenosis, and ischemia. The Medtronic LINQ II is an insertable cardiac monitor, requiring a minimally invasive procedure for subcutaneous placement, which then continuously records subcutaneous ECG data for up to 4.5 years.
Cleerly ISCHEMIA utilizes AI for CCTA analysis, including non-invasive fractional flow reserve (FFR) estimation, vessel-level ischemia likelihood determination, and comprehensive coronary plaque characterization. The Medtronic LINQ II features AccuRhythmu2122 AI algorithms for enhanced accuracy in detecting arrhythmias, including an innovative PVC detection algorithm, and remote programming capability.
Cleerly ISCHEMIA provides an analysis of a CCTA scan at a specific point in time, generating a comprehensive report based on that single scan. The Medtronic LINQ II offers long-term, continuous heart rhythm monitoring for up to 4.5 years.
Cleerly ISCHEMIA operates on a web-based platform with data transfer via Cleerly Proxy and offers comprehensive interactive web-based reports, with integration capabilities via API with PowerScribe. The Medtronic LINQ II transmits data via the MyCareLink Heartu2122 mobile app or the MyCareLink Relayu2122 home communicator, sending information directly to the doctor's office.
Cleerly ISCHEMIA is indicated for aiding physicians in personalized diagnosis and treatment planning for heart disease by assessing the likelihood of coronary artery ischemia in patients undergoing CCTA. The Medtronic LINQ II is suitable for adult and pediatric patients (ages 2 and older) experiencing transient symptoms like dizziness, palpitations, syncope, and chest pain that may suggest a cardiac arrhythmia, requiring long-term monitoring.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform
AISAP Cardio vs Rapid Enterprise Platform
AngioWaveNet vs Rapid Enterprise Platform
CorVista System with PH Add-On vs Rapid Enterprise Platform

More matchups featuring Cleerly ISCHEMIA or LINQ II Insertable Cardiac Monitor

Backers

Who funded each tool's parent company.

Cleerly ISCHEMIA

AI Tool Finder
AI-powered search. Results may not be comprehensive.